← Back to Clinical Trials
Recruiting NCT06648421

NCT06648421 Reference Values for the One Repetition Maximum Test of Knee Extensors for Brazilians.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06648421
Status Recruiting
Phase
Sponsor Universidade Estadual de Londrina
Condition Healthy
Study Type OBSERVATIONAL
Enrollment 72 participants
Start Date 2024-07-07
Primary Completion 2026-02-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 72 participants in total. It began in 2024-07-07 with a primary completion date of 2026-02-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Muscle strength is important for health and can affect how well people live, even increasing the risk of death in adults and older people. The one-repetition maximum (1RM) test is relatively easy compared to other tests and is commonly used to measure muscle strength in various groups, including healthy individuals and those with chronic diseases. It assists in prescribing resistance training and understanding training results. Knee extensors, especially the quadriceps femoris, are often studied because they play a key role in standing and walking. However, there are no standard reference values or equations for measuring knee extensors using the 1RM test. The existing methods rely on the evaluator's judgment, making them hard to replicate and standardize. The goal of this study is to provide reference equations and values for the 1RM of knee extensors and to establish a standardized methodology for the test.

Eligibility Criteria

Inclusion Criteria: * Individuals aged between 18-80 years of both sexes; * Absence of any condition (e.g., orthopedic, neuromuscular, cardiorespiratory) that may limit the assessment or directly interfere in its results. Exclusion Criteria: * Failure to complete the proposed assessments for any reason; * A score on the Mini-Mental State Examination lower than18 for illiterate individuals and lower than 24 for literate individuals; * Body mass index (BMI) lower than 18 kg/m2 and higher than 40 kg/m2; * The manifestation of the desire to leave the study at any time for any reason.

Contact & Investigator

Central Contact

Fabio O Pitta, PhD

✉ fabiopitta@uel.br

📞 +5543991015480

Principal Investigator

Fabio O Pitta, PhD

PRINCIPAL INVESTIGATOR

State University of Londrina

Frequently Asked Questions

Who can join the NCT06648421 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06648421 currently recruiting?

Yes, NCT06648421 is actively recruiting participants. Contact the research team at fabiopitta@uel.br for enrollment information.

Where is the NCT06648421 trial being conducted?

This trial is being conducted at Londrina, Brazil.

Who is sponsoring the NCT06648421 clinical trial?

NCT06648421 is sponsored by Universidade Estadual de Londrina. The principal investigator is Fabio O Pitta, PhD at State University of Londrina. The trial plans to enroll 72 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology